Based on the forest plots of absolute survival differences in Fig. 4C and HRs in Fig. 4D there seemed to be more studies reporting a worse breast cancer-specific survival for BRCA2 compared to ‘non-carriers’ than studies reporting a better breast cancer-specific survival (S5 Supporting Information, part B). The gene discussed is BRCA2; the disease is breast carcinoma.